Skip to main content
CY

Cytotrait

Manchester, United Kingdom
Last funding
$4.0M
SeedMar 2026

Cytotrait (previously Plant Organelle Technologies) focuses on the development of novel traits for food and agriculture.

Backed byNorthern Universities Venture FundNorthern GritstoneARIAUK Innovation & Science Seed Fund

About Cytotrait

How much funding has Cytotrait raised?

Cytotrait has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are Cytotrait's investors?

Cytotrait's investors include Northern Universities Venture Fund, Northern Gritstone, ARIA, UK Innovation & Science Seed Fund.

Where is Cytotrait headquartered?

Cytotrait is headquartered in Manchester, United Kingdom.

What does Cytotrait do?

Cytotrait (previously Plant Organelle Technologies) focuses on the development of novel traits for food and agriculture.

What stage is Cytotrait at?

Cytotrait is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cytotrait — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/cytotrait. Accessed November 21, 2026.
APA
VCBacked. (2026). Cytotrait — Funding & Investors. Retrieved November 21, 2026, from https://www.vcbacked.co/company/cytotrait
Wikipedia (cite web)
{{cite web |title=Cytotrait — Funding & Investors |url=https://www.vcbacked.co/company/cytotrait |website=VCBacked |access-date=November 21, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Cytotrait? Request a listing update

Founder contacts
m***@cytotrait.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →